Kosenar,The above speaker notes can be found on the IMAPAC...

Kosenar,
The above speaker notes can be found on the IMAPAC website (context is last Bioplasma World Conference)
http://www.imapac.com/index.php?page=BioplasmaWorldAsia2013Speaker

"Dr Hari Nair,
Executive Chairman,
Prime Biologics Pte Ltd

Dr Hari Nair is the Executive Chairman of Prime Biologics Pte Ltd in Singapore. He has a doctorate in Medicine and Clinical Science and has authored around seventy medical and scientific publications in Haematology and Cardiovascular medicine. He has had a long history of involvement in managing publically listed companies and was the Managing Director of the one of the largest plasma collection companies in the US, Life Therapeutics. Dr Nair together has set up a number of companies and been involved in capital raisings for start ups. Dr Nair is an expert in Coagulation and Haemostasis with a special interest in cardiovascular disease and fibrinogen. He has, over the last many years, worked on new technologies in plasma protein fractionation and is the co-inventor of the PrIME technology which is now being adopted by Prime Biologics in Singapore to establish South East Asia’s first plasma fractionation facility. He is the author of a number of patents in the plasma fractionation and protein purification areas. Dr Nair is also on the board of NuSep Limited in Australia as its Deputy Chairman."

If you look at the calibre of the other speakers at this conference and note Dr Nair's standing amongst them, then I submit that it would be hard to argue that he is other than a leading authority in his field. Can you name anyone else in Australia who has "authored around seventy medical and scientific publications in Haematology and Cardiovascular medicine?"

Hope this reply assists you Kosenar. Remember that at least one other medical scientist working collaboratively with NuSep has been honoured for his work in recent times. You know the old saying "...birds of a feather flock together". Do you want to argue that our highly valued IP comes from other than a team of highly credentialed medical scientists?

As always DYOR.

Kind regards,